Citations

Showing 10 of 108083 citations.

Vascular age, cardiovascular disease risk factors, and hematological parameters in patients with Schizophrenia: An exploratory study
Vyas, Hridyanshu , Nebhinani, Naresh , Suthar, Navratan , Sharma, Praveen

Mayo Clinic

Journal of Neurosciences in Rural Practice | December 21, 2022 | Volume: 14 | Issue: No issue available | Pages: 149-153

10.25259/jnrp-2022-7-6 | PMID 36891120 Get It

Objectives: Patients with schizophrenia have shortened life expectancy due to greater cardiovascular disease (CVD) risk. Due to sparse data, index study was planned to assess the CVD risk factors, vascular age (VA), and hematological parameters in patients with schizophrenia and the concordance between Framingham Risk Score (FRS) for lipids and body mass index (BMI) (FRSLIPIDS and FRSBMI). Materials and Methods: Patients with schizophrenia (n = 53) were evaluated for the presence of metabolic syndrome (MS) using the modified NCEP ATP III criteria, along with their functionality, illness severity, physical activity and nutritional score, FRSLIPIDS and FRSBMI, and hematological parameters. Results: Prevalence of MS was 39.6%; in addition, 47% of patients were at risk for developing MS as they fulfilled one or two components of MS criteria and 56% of patients were obese. BMI, obesity, and RBC count were found as significant correlates for MS. CVD risk (FRS) median score (3.10) was comparable for BMI and lipid criteria along with significant correlation for FRSLIPIDS and FRSBMI (r = 0.555, P < 0.001). Conclusion: VA and 10-year CVD risk (FRS for BMI and lipid criteria) represent easier way to communicate with the patients and caregivers and also to guide for comprehensive treatment plan, appropriate nutrition, physical activity, and cardiometabolic screening.
The evolution of frontline therapy for adult Philadelphia‐positive acute lymphoblastic leukemia: Giant strides and ongoing challenges
Saliba, Antoine N. , Foà, Robin , Saliba, Antoine N. , Saliba, Antoine N , Saliba, Antoine N

Mayo Clinic

American Journal of Hematology | December 21, 2022 | Volume: 98 | Issue: 3 | Pages: 374-376

10.1002/ajh.26813 | PMID 36540957 Get It

Dynamic monitoring of minimal residual disease in newly‐diagnosed multiple myeloma
Yang, Pei‐Yu , Xu, Weiling , Liang, Xinyue , Yu, Shanshan , Yi, Xingcheng , Liu, Mengmeng , Tian, Mengru, Yue, Tingting , Yan, Yurong, Hu, Zhongli, Zhang, Nan , Wang, Jingxuan , Hu, Rui , Kumar, Shaji , Jin, Fengyan , Kumar, Shaji K , Dai, Yun , Jin, Fengyan , Yue, Tingting, Zhang, Yingjie , Guo, Qiang , Sun, Xiaoxiao , Dai, Yun

Mayo Clinic

American Journal of Hematology | December 21, 2022 | Volume: 98 | Issue: 3 | Pages: No page available

10.1002/ajh.26810 | PMID 36540935 Get It

Allogeneic stem cell transplant improves survival after first- or second-line therapy in TP53-mutated acute myeloid leukemia: Results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).
Badar, Talha , Shallis, Rory M. , Patel, Anand , Grenet, Justin , Stahl, Maximilian , Burkart, Madelyn , Palmisiano, Neil , Bradshaw, Danielle , Kubiak, Michal , Dinner, Shira, Litzow, Mark R. , Patel, Anand , Badar, Talha , Burkart, Madelyn , Atallah, Ehab , Saliba, Antoine N. , Bewersdorf, Jan Philipp , DuVall, Adam , Goldberg, Aaron D. , Abaza, Yasmin , Murthy, Guru Subramanian Guru , Kota, Vamsi

Mayo Clinic

No container title available | December 21, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2383293/v1 Get It

Abstract We conducted a multi-center study to analyze factors predicting survival among patients with TP53-mutated (m) AML receiving allogeneic hematopoietic stem cell transplant (allo-HSCT) in the recent era. Among 370 patients, 68 (18%) patients were bridge to allo-HSCT. The median age of the patients was 63 years (range, 33–75), 82% of patients had complex cytogenetics and 66% of patients had multi-hit TP53m. Forty three percent received myeloablative conditioning (MAC) and 57% received reduced intensity conditioning (RIC). The incidence of acute graft versus host disease (GVHD) was 37% and chronic GVHD was 44%. The median event-free survival (EFS) from the time of allo-HSCT was 12.4 months (95% CI: 6.24–18.55) and median overall survival (OS) was 24.5 months (95% CI: 21.80-27.25). In multivariate analysis utilizing variables that showed significance in univariate analysis, complete remission at day 100 post allo-HSCT retained significance for EFS (HR: 0.24, 95% CI: 0.10–0.57, p = 0.001) and OS (HR: 0.22, 95% CI: 0.10–0.50, p = < 0.001). Similarly, occurrence of chronic GVHD retained significance for EFS (HR: 0.21, 95% CI: 0.09–0.46, p = < 0.001) and OS (HR: 0.34, 95% CI: 0.15–0.75, p = 0.007). Our report suggests that allo-HSCT offers the best opportunity to improve long-term outcome among patients with TP53m AML.
Long-Term Patient-Reported Outcomes After Arthroscopic Debridement of Grade 3 or 4 Capitellar Osteochondritis Dissecans Lesions
Austin, Daniel C. , Song, Bryant M. , Lievano, Jorge L Rojas, Rogers, Thomas H., Sanchez-Sotelo, Joaquin L., Liévano, Jorge Rojas , Song, Bryant, Rojas Lievano, Jorge L, O'Driscoll, Shawn W., Lievano, Jorge Rojas , Rogers, Thomas H., Barlow, Jonathan D. , Camp, Christopher L. , Morrey, Mark E. , Sánchez‐Sotelo, Joaquín , Fitzsimmons, James S. , O’Driscoll, Shawn W.

Mayo Clinic

The American Journal of Sports Medicine | December 21, 2022 | Volume: 51 | Issue: 2 | Pages: 351-357

10.1177/03635465221137894 | PMID 36541470 Get It

Background: Arthroscopic debridement for osteochondritis dissecans (OCD) lesions of the capitellum is a relatively common and straightforward surgical option for failure of nonoperative management. However, the long-term outcomes of this procedure remain unknown. Hypothesis: Arthroscopic debridement of capitellar OCD would provide satisfactory long-term improvement in patient-reported outcomes. Study Design: Case series; Level of evidence, 4. Methods: Patients aged ≤18 years who underwent arthroscopic debridement procedures for OCD lesions (International Cartilage Repair Society grades 3 and 4) were identified. Procedures included loose body removal when needed and direct debridement of the lesion; marrow stimulation with drilling or microfracture was added at the discretion of each surgeon. The cohort consisted of 53 elbows. Patient evaluation included visual analog scale for pain; motion; subjective satisfaction; Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) scores; reoperation; and rate of return to sports. Results: At a mean 11 years of follow-up (range, 5-23 years), the median visual analog scale score for pain was 0, and 96% of patients reported being improved as compared with how they were before surgery. The mean ± SD QuickDASH score was 4 ± 9 points (range, 0-52 points), and 80% of patients returned to their sports of interest. The arc of motion significantly improved from 115°± 28° preoperatively to 130°± 17° at latest follow-up ( P = .026). Seven elbows (13%) required revision surgery for OCD lesions, resulting in high rates of overall survivorship free of revision surgery: 90% (95% CI, 80%-96%) at 5 years and 88% (95% CI, 76%-94%) at 10 years. At final follow-up, 7 all-cause reoperations were performed without revision surgery on the OCD lesion. Conclusion: Arthroscopic debridement of grade 3 or 4 OCD lesions of the capitellum produced satisfactory patient-reported outcomes in a majority of elbows, although a subset of patients experienced residual symptoms. The inherent selection bias of our cohort should be considered when applying these results to the overall population with OCD lesions, as we do not recommend this procedure for all patients.
Acute responsiveness to single leg cycling in adults with obesity
Gries, Kevin J. , Hart, Corey R., Ryan, Zachary, Zhang, Xiaoyan , Parvizi, Mojtaba, Liu, Yuanhang , Dasari, Surendra , Lanza, Ian R , Kunz, Hawley , Lanza, Ian R.

Mayo Clinic

Physiological Reports | December 21, 2022 | Volume: 10 | Issue: 24 | Pages: No page available

10.14814/phy2.15539 | PMID 36541258 Get It

Abstract Obesity is associated with several skeletal muscle impairments which can be improved through an aerobic exercise prescription. The possibility that exercise responsiveness is diminished in people with obesity has been suggested but not well‐studied. The purpose of this study was to investigate how obesity influences acute exercise responsiveness in skeletal muscle and circulating amino metabolites. Non‐obese (NO; n = 19; 10F/9M; BMI = 25.1 ± 2.8 kg/m 2 ) and Obese (O; n = 21; 14F/7M; BMI = 37.3 ± 4.6 kg/m 2 ) adults performed 30 min of single‐leg cycling at 70% of VO 2 peak. 13 C 6 ‐Phenylalanine was administered intravenously for muscle protein synthesis measurements. Serial muscle biopsies (vastus lateralis) were collected before exercise and 3.5‐ and 6.5‐h post‐exercise to measure protein synthesis and gene expression. Targeted plasma metabolomics was used to quantitate amino metabolites before and 30 and 90 min after exercise. The exercise‐induced fold change in mixed muscle protein synthesis trended ( p = 0.058) higher in NO (1.28 ± 0.54‐fold) compared to O (0.95 ± 0.42‐fold) and was inversely related to BMI (R 2 = 0.140, p = 0.027). RNA sequencing revealed 331 and 280 genes that were differentially expressed after exercise in NO and O, respectively. Gene set enrichment analysis showed O had six blunted pathways related to metabolism, cell to cell communication, and protein turnover after exercise. The circulating amine response further highlighted dysregulations related to protein synthesis and metabolism in adults with obesity at the basal state and in response to the exercise bout. Collectively, these data highlight several unique pathways in individuals with obesity that resulted in a modestly blunted exercise response.
Update on management of paediatric dyslipidaemia
Bansal, Nidhi , Kumar, Seema , Brar, Preneet Cheema

Mayo Clinic

Current Opinion in Endocrinology, Diabetes & Obesity | December 21, 2022 | Volume: 30 | Issue: 1 | Pages: 52-64

10.1097/med.0000000000000794 | PMID 36541082 Get It

Purpose of review Atherosclerosis and associated cardiovascular risk factors originate in childhood; hence, early management of dyslipidaemia is vital. However, hypercholesterolemia remains untreated or undertreated in many youths. We review current therapies, drugs under investigation and consider potential future directions for the management of paediatric dyslipidaemia to highlight the recent evidence and new therapeutic options for future use. Recent findings Cardiovascular disease (CVD) risk factors in childhood, including dyslipidaemia, are associated with CVD risk and clinical CVD events in adulthood. Recent data show that initiation of statin therapy in childhood in children with familial hypercholesterolemia reduces the risk of CVD in adulthood. Several well tolerated and efficacious treatment options have become available in recent times for the management of dyslipidaemia in youth. Many new lipid-lowering drugs are under investigation to widen the available choices. Some of these drugs are now available for use in paediatrics, while some remain targets for future use. Summary We review available treatment options for paediatric dyslipidaemia management, discuss potential limitations and propose future directions. We also acknowledge the need for continued research in paediatrics for optimal paediatric dyslipidaemia management.
Neurophenotypes of COVID-19: risk factors and recovery trajectories
Prabhakaran, Divya , Day, Gregory S. , Munipalli, Bala, Rush, Beth K., Pudalov, Lauren, Niazi, Shehzad K. , Brennan, Emily, Durvasula, Ravi, Athreya, Arjun, Blackmon, Karen , Day, Gregory S , Powers, Harry

Mayo Clinic

No container title available | December 21, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2363210/v1 Get It

Abstract Coronavirus disease 2019 (COVID-19) infection is associated with risk of persistent neurocognitive and neuropsychiatric complications, termed “long COVID”. It is unclear whether the neuropsychological manifestations of COVID-19 present as a uniform syndrome or as distinct neurophenotypes with differing risk factors and recovery trajectories. We examined post-acute outcomes following SARS-CoV-2 infection in 205 patients recruited from inpatient and outpatient populations, using an unsupervised machine learning cluster analysis, with objective and subjective neuropsychological measures as input features. This resulted in three distinct post-COVID clusters. In the largest cluster (69%), cognitive functions were within normal limits (“normal cognition” neurophenotype), although mild subjective attention and memory complaints were reported. Cognitive impairment was present in the remaining 31% of the sample but clustered into two differentially impaired groups. In 16% of participants, memory deficits, slowed processed speed, and fatigue were predominant. Risk factors for membership in the “memory-speed impaired” neurophenotype included anosmia and more severe COVID-19 infection. In the remaining 15% of participants, executive dysfunction was predominant. Risk factors for membership in this milder “dysexecutive” neurophenotype included disease-nonspecific factors such as neighborhood deprivation and obesity. Recovery trajectories at 6-month follow-up differed across neurophenotypes, with the normal cognition group showing stability, the dysexecutive group showing improvement, and the memory-speed impaired group showing persistent processing speed deficits and fatigue, as well as worse functional outcomes. These results indicate that there are multiple post-acute neurophenotypes of long COVID, with different etiological pathways and recovery trajectories. This information may inform phenotype-specific approaches to treatment.
Adaptive chin rest device for optimizing visual field testing
Dogahe, Sepideh Jamali, Wentworth, Adam, Sadeghmousavi, Mostafa, Khanna, Cheryl L. , Khanna, Sunil

Mayo Clinic

Acta Ophthalmologica | December 21, 2022 | Volume: 100 | Issue: S275 | Pages: No page available

10.1111/j.1755-3768.2022.0097 Get It

AbstractPurpose: Evaluation of an adjustable chin rest apparatus for visual field machine.Methods: The HFA 60‐4 visual field test was performed in the primary position and then repeated in the optimum head turn angle using an adjustable chin rest to maximize a visual field for each subject. The optimum head turn angle was calculated using a 3D face model. A 3D model of the face of the subjects was reconstructed using a single facial photo and a Convolutional Neural Networks (CNN), which is a deep learning algorithm. The angles between visual axis and all points around it on the face surface were calculated and the points on the 3D face model with the angle less than 60 degrees was used to predict the optimal head turn angle. A chin rest apparatus for a visual field system was made by 3D printing. The chin rest apparatus includes a moveable chin rest insert coupled to the base and configured to be adjusted to one of a plurality of head turn angles.Results: Three eyes from three healthy subjects (2 female and 1 male) with the mean age of 27.33, CI: 7.37 were enrolled. The visual field defects cause by the facial contour of the subject was decreased by turning the subject's head relative to a vertical axis away from (nasally) the eye being tested using a visual field system with the adaptive chin rest. The mean threshold of the visual field tests of all eyes in the primary angle and optimized angle was 1496, CI: 380.22 and 1567.67, CI: 295.37 respectively. Mean of the degree of head turn to maximize the visual field for all individuals was 6.67 degrees, CI: 2.88.Conclusions: The described adaptive chin rest can be used to position a subject's head at an optimal head turn angle that minimizes the visual field defects caused by the facial contours and maximizes the measured visual field of the subject. This technology can be used in far peripheral visual field tests for early detection of glaucoma as well as accurate follow up of disease progression.
Clinical Practice Evolvement for Post-Operative Prostate Cancer Radiotherapy—Part 1: Consistent Organs at Risk Management with Advanced Image Guidance
Laughlin, Brady S. , Lo, Stephanie, Vargas, Carlos , Walt, Charles Van Der , Tinnon, Katie, Beckett, Mason, Hobbis, Dean , Wong, William W. , Keole, Sameer R., Rwigema, Jean‐Claude M. , Yu, Nathan Y. , Clouser, Edward , Van der Walt, Charles, Schild, Steven E. , Clouser, Edward Lee , Laughlin, Brady S , DeWees, T.A. , Rong, Yi

Mayo Clinic

Cancers | December 21, 2022 | Volume: 15 | Issue: 1 | Pages: 16

10.3390/cancers15010016 | PMID 36612013 Get It

Purpose: Post-operative prostate cancer patients are treated with full bladder instruction and the use of an endorectal balloon (ERB). We reassessed the efficacy of this practice based on daily image guidance and dose delivery using high-quality iterative reconstructed cone-beam CT (iCBCT). Methods: Fractional dose delivery was calculated on daily iCBCT for 314 fractions from 14 post-operative prostate patients (8 with and 6 without ERB) treated with volumetric modulated radiotherapy (VMAT). All patients were positioned using novel iCBCT during image guidance. The bladder, rectal wall, femoral heads, and prostate bed clinical tumor volume (CTV) were contoured and verified on daily iCBCT. The dose-volume parameters of the contoured organs at risk (OAR) and CTV coverage were assessed for the clinical impact of daily bladder volume variations and the use of ERB. Minimum bladder volume was studied, and a straightforward bladder instruction was explored for easy clinical adoption. Results: A “minimum bladder” contour, the overlap between the original bladder contour and a 15 mm anterior and superior expansion from prostate bed PTV, was confirmed to be effective in identifying cases that might fail a bladder constraint of V65% <60%. The average difference between the maximum and minimum bladder volumes for each patient was 277.1 mL. The daily bladder volumes varied from 62.4 to 590.7 mL and ranged from 29 to 286% of the corresponding planning bladder volume. The bladder constraint of V65% <60% was met in almost all fractions (98%). CTVs (D90%, D95%, and D98%) remained well-covered regardless of the absolute bladder volume daily variation or the presence of the endorectal balloon. Patients with an endorectal balloon showed smaller variation but a higher average maximum rectal wall dose (D0.03mL: 104.3% of the prescription) compared to patients without (103.3%). Conclusions: A “minimum bladder” contour was determined that can be easily generated and followed to ensure sufficient bladder sparing. Further analysis and validation are needed to confirm the utility of the minimal bladder contour. Accurate dose delivery can be achieved for prostate bed target coverage and OAR sparing with or without the use of ERB.